Get Help Now

Contact a Lawyer in
North or South Carolina.


Risperdal® is an antipsychotic drug used to treat a variety of mental and mood disorders, including schizophrenia, bipolar disorder, and irritability associated with autism. However, use of the drug has been linked to gynecomastia, or the development of large male breasts, in young boys and adolescents.

Gynecomastia can cause pain and tenderness in the breasts, as well as mental and emotional distress, and often requires surgical removal of glands and tissues to correct.

If you or your child took Risperdal as a minor before 2008 and developed gynecomastia, you may be eligible for compensation. Minors who took Risperdal’s generic equivalent, risperidone—manufactured by Patriot Pharmaceuticals—may also be eligible for compensation. Contact Crumley Roberts today—call or complete a free initial consultation form.

Risperdal® Health Risks for Children

Risperdal was approved by the FDA to treat certain psychiatric conditions in children in 2006 and 2007. However, Bloomberg uncovered that Johnson & Johnson, the maker of Risperdal, marketed the drug to doctors who work with troubled children before it was approved for pediatric use.

Research has shown the risks Risperdal can pose to children. The largest study on the side effects of the drug in adolescents and children showed hormonal changes in male patients that triggered the development of gynecomastia. In the study, 3 out of 10 male adolescents developed the condition, and researchers concluded that Risperdal should be administered to children and adolescents with caution.

Get Compensation for Your Risperdal® Drug Injury

Families shouldn’t have to pay because a drug company put money before safety. If your child was a minor who took Risperdal, or its generic equivalent, before 2008 and developed gynecomastia, we want to speak with you. Our Risperdal injury attorneys are here to help you get the money you need for medical bills, pain and suffering, and more. Don’t suffer in silence any longer—contact us now.

Risperdal® is a registered trademark of Johnson & Johnson, and is used here only to identify the product in question.

This law firm is not associated with, sponsored by, or affiliated with Bloomberg L.P.; Johnson & Johnson; the Journal of Clinical Psychopharmacology; the National Center for Biotechnology Information; Patriot Pharmaceuticals, LLC; or the U.S. Food and Drug Administration.

Free Initial Consultation